Since then, emerging studies have shown that high levels of TK1 expression are a predictive factor in the assessment of early screening, diagnosis, progression, and treatment effects of several cancers, including lung, ovarian, colon, cervix, breast, kidney, prostate, and hematological malignancies [8,9,10,11,12,13]. The gene discussed is TK1; the disease is cancer.